Furthermore, IL-2 treatment exerted effects of anti-anxiety and anti-depression, such as increasing the number of entries into (p = 0.039) and the time spent (p = 0.0061) on the open arms, as well as decreasing the immobility time in the suspension tail test (p = 0.0443). This evidence concerns the gene IL2 and major depressive disorder.